Tickertape - Financial freedom begins here

Tilaknagar Industries Limited announced the completion of the first tranche of an investment in Black Tiger Distilleries Private Limited, amounting to Rs 5,99,99,957.36, for the subscription of 14,628 compulsorily convertible preference shares and 100 equity shares, resulting in Tilaknagar Industries holding approximately 12.5% of the paid-up share capital of Black Tiger Distilleries on a fully diluted basis.

Mufin Green Finance Limited informed the BSE Limited and National Stock Exchange of India that its Nomination and Remuneration Committee approved the grant of 8,53,484 stock options under the Mufin Green Finance Limited - Employee Stock Option Plan 2023 (ESOP Scheme 2023) to eligible employees, with an exercise price of Rs 70 per option.

Rossell Techsys Limited will hold a board meeting on September 18, 2026, to consider a proposal for the issuance of equity shares via preferential allotment to certain investors, in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and the Companies Act, 2013, and will convene an extraordinary general meeting to seek shareholder approval for the fund raising.

The offer received bids for 17.76 crore units as against 2.14 crore units on offer. The initial public offer of Manika Plastech Ltd IPO received bids for 17,76,05,976 units as against 2,13,86,919 units on offer, according to stock exchange data at 20:12 IST on Tuesday (15 September 2026). The issue was subscribed 8.30 times. The issue opened for bidding on Friday, 11 September 2026 and it will close on Wednesday, 16 September 2026. The price band of the IPO is fixed at Rs 40 per share to 43 per share. An investor can bid for a minimum of 348 equity shares and in multiples thereof. The REIT IPO comprises a fresh issue of Rs 92 crore and an offer for sale of Rs 33 crore, aggregating to a total issue size of Rs 125 crore.

The offer received bids for 15.33 crore units as against 1.13 crore units on offer. The initial public offer of Veegaland Developers Ltd IPO received bids for 15,32,74,397 units as against 1,13,07,692 units on offer, according to stock exchange data at 20:12 IST on Tuesday (15 September 2026). The issue was subscribed 13.55 times. The issue opened for bidding on Thursday, 10 September 2026 and it will close on Tuesday, 15 September 2026. The price band of the IPO is fixed at Rs 130 per share to 140 per share. An investor can bid for a minimum of 107 equity shares and in multiples thereof. The REIT IPO comprises a fresh issue of Rs 210 crore , aggregating to a total issue size of Rs 210 crore.

Alkem Laboratories Limited announced the appointment of Dr. Shubhadeep Sinha to a senior management position, effective September 15, 2026, according to a regulatory filing with the Bombay Stock Exchange and National Stock Exchange of India. The duration of Dr. Sinha’s appointment will be for as long as he remains employed by the company, and he brings over 25 years of experience in clinical development, medical affairs, and regulatory affairs.

Esaar (India) Limited announced that its Rights Issue Committee approved the allotment of 5,99,64,667 fully paid-up equity shares of Rs. 10 face value each at a price of Rs. 10 per share, aggregating up to Rs 5996.47 Lakhs, following a subscription period that ran from September 2 to September 11, 2026, with Purva Sharegistry (India) Private Limited acting as the Registrar to the Issue and BSE Limited as the Designated Stock Exchange. The company's paid-up equity share capital increased from Rs. 20,44,25,000 divided into 2,04,42,500 shares to Rs. 80,40,71,670 divided into 8,04,07,167 shares.

Esaar (India) Limited announced that its Rights Issue Committee approved the allotment of 5,99,64,667 fully paid-up equity shares of Rs. 10 each to eligible shareholders at a price of Rs. 10 per share, aggregating up to Rs 5996.47 Lakhs. The Rights Issue opened on September 2, 2026, and closed on September 11, 2026, with Purva Sharegistry (India) Private Limited acting as the Registrar to the Issue and BSE Limited as the Designated Stock Exchange.

V.I.P. Industries Limited will hold a board meeting on Friday, September 18, 2026, to consider and evaluate a proposal to raise funds through the issuance of equity shares, debt securities, convertible securities, depository receipts, FCCBs, warrants, preference shares, or other financial instruments, by way of a public issue, rights issue, qualified institutions placement, debt issue, preferential issue, or any other permissible mode. Trading in the company's securities has been suspended for designated persons from September 12, 2026, until September 20, 2026.

ZIM Laboratories Limited announced that its wholly-owned subsidiary, ZIM Laboratories Limited FZE, has completed an investment of AED 4,66,000 and AED 4,50,000 in ZIM Scientific Office LLC, a step-down subsidiary, as previously disclosed on March 28, 2025, and August 7, 2025, maintaining ZIM FZE’s 100% shareholding in ZIM SO.